Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome

Journal of Neural Transmission

Volumn 122, Issue 6, 2015, Pages 819-823

  Jiménez Jiménez, Félix Javier ^a,b   Alonso Navarro, Hortensia ^a,b   Martínez, Carmen ^c   Zurdo, Martín ^d   Turpín Fenoll, Laura ^e   Millán Pascual, Jorge ^e   Adeva Bartolomé, Teresa ^f   Cubo, Esther ^g   Navacerrada, Francisco ^a   Rojo Sebastián, Ana ^b   Rubio, Lluisa ^b   Calleja, Marisol ^a   Plaza Nieto, José Francisco ^a   Pilo de la Fuente, Belén ^a   Arroyo Solera, Margarita ^a   García Albea, Esteban ^b   García Martín, Elena ^c   Agúndez, José A G ^c  

^a Hospital Universitario del Sureste de Madrid   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c UNIVERSITY OF EXTREMADURA   (Spain)

^d HOSPITAL VIRGEN DEL PUERTO   (Spain)

^e HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^f Unit of Neurology   (Spain)

^g HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Genetics; Nitric oxide; NOS1 gene; Oxidative stress; Polymorphisms; Restless legs syndrome; Risk factors

Indexed keywords

CLONAZEPAM; FERRITIN; GABAPENTIN; PREGABALIN; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; GERMAN (CITIZEN); HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; NEURONAL NITRIC OXIDE SYNTHASE GENE; ONSET AGE; PRIORITY JOURNAL; REPLICATION STUDY; RESTLESS LEGS SYNDROME; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SPANIARD; TREATMENT RESPONSE; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; RISK;

COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE I; POLYMORPHISM, SINGLE NUCLEOTIDE; RESTLESS LEGS SYNDROME; RISK;

EID: 84930225109     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1322-z     Document Type: Article

References (18)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology work shop at the National Institute of Health. Sleep Med 4:101–119
2. Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelmann JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria—history, rationale, description, and significance. Sleep Med 15:860–873
3. Baskol G, Korkmaz S, Erdem F, Caniklioglu A, Kocyigit M, Aksu M (2012) Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep Med 13:414–418
4. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1:289–300
5. Clemens S, Sawchuk MA, Hochman S (2005) Reversal of the circadian expression of tyrosine-hydroxylase but not nitric oxide synthase levels in the spinal cord of dopamine D3 receptor knockout mice. Neuroscience 133:353–357
6. Ekbom KA (1945) Restless legs. Acta Med Suppl 158:5–123
7. Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG (2013a) Latest perspectives in genetic risk factors for restless legs syndrome. Eur Neurol Rev 8:90–96
8. Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, Agúndez JAG, García-Martín E (2013b) Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome. Sleep Med 14:382–384
9. Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Martín E, Agúndez JAG (2014) The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome. Sleep Med 15:266–268
10. Kiss JP, Hennings EC, Zsilla G, Vizi ES (1999) A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum. Neurochem Int 34:345–350
11. Liu Y (1996) Nitric oxide influences dopaminergic processes. Adv Neuroimmunol 6:259–264
12. Molina JA, Jiménez-Jiménez FJ, Ortí-Pareja M, Navarro JA (1998) The role of nitric oxide in neurodegeneration: potential for pharmacological intervention. Drugs Aging 12:251–259
13. Patton SM, Ponnuru P, Snyder AM, Podskalny GD, Connor JR (2011) Hypoxia-inducible factor pathway activation in restless legs syndrome patients. Eur J Neurol 18:1329–1335
14. Roco A, Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Martín E, Agúndez JA (2013) MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome. J Neural Transm 120:463–467
15. Segovia G, Mora F (1998) Role of nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Res Bull 45:275–279
16. Ulfberg J (2012) Treatment of restless legs syndrome with a nitroglycerin patch. Sleep Med 13:1326
17. West AR, Galloway MP (1997) Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology 36:1571–1581
18. Winkelmann J, Lichtner P, Schormair B, Uhr M, Hauk S, Stiasny-Kolster K, Trenkwalder C, Paulus W, Peglau I, Eisensehr I, Illig T, Wichmann HE, Pfister H, Golic J, Bettecken T, Pütz B, Holsboer F, Meitinger T, Müller-Myhsok B (2008) Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord 23:350–358